What does this research mean for the field?

Progressive epigenetic-transcriptional dysregulation drives pulmonary nodule malignancy, and a 9-gene cell-free DNA methylation classifier derived from these multiomic insights can accurately and noninvasively diagnose malignant nodules. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to distinguish malignant from benign pulmonary nodules using multiomic approaches and develop a methylation-based diagnostic model.

June 11, 2026Journal of Translational MedicineOpen Access

Multiomic characterization of malignant pulmonary nodules and development of a methylation-based diagnostic Model

View Full Paper

Ask AI

Bookmark

Authors

WZWei Zhou TXTongji Xie QWQingjun Wu

Discussion

Member takes

Overview

Randomized trial demonstrates a methylation-based classifier for diagnosing pulmonary nodules, suggesting a noninvasive diagnostic innovation.

Key Points

This research aims to distinguish malignant from benign pulmonary nodules using multiomic approaches and develop a methylation-based diagnostic model.
Characterization of 158 pulmonary nodules through genomic, epigenomic, and transcriptomic profiling.
Employing unsupervised factor analysis to identify core regulatory axes in nodules.
Validation of a 9-gene cfDNA methylation classifier in blood and tissue cohorts.
EGFR mutations were found exclusively in malignant nodules, indicating key drivers of malignancy.
The 9-gene cfDNA methylation classifier demonstrated a training AUC of 1.00, test AUC of 0.93, and tissue AUC of 0.96, showing exceptional accuracy.
Progressive methylation changes correlate with tumor aggressiveness, providing insights into lung cancer progression.

Cite This Study

Zhou et al. (2026) studied this question.

synapsesocial.com/papers/6a2a503380c8f91e7f39cb95 https://doi.org/10.1186/s12967-026-08382-w

View Full Paper

Ask AI

Bookmark

June 11, 2026Journal of Translational MedicineOpen Access

Multiomic characterization of malignant pulmonary nodules and development of a methylation-based diagnostic Model

View Full Paper

Ask AI

Bookmark

Authors

WZWei Zhou TXTongji Xie QWQingjun Wu

Discussion

Member takes

Overview

Randomized trial demonstrates a methylation-based classifier for diagnosing pulmonary nodules, suggesting a noninvasive diagnostic innovation.

Key Points

This research aims to distinguish malignant from benign pulmonary nodules using multiomic approaches and develop a methylation-based diagnostic model.
Characterization of 158 pulmonary nodules through genomic, epigenomic, and transcriptomic profiling.
Employing unsupervised factor analysis to identify core regulatory axes in nodules.
Validation of a 9-gene cfDNA methylation classifier in blood and tissue cohorts.
EGFR mutations were found exclusively in malignant nodules, indicating key drivers of malignancy.
The 9-gene cfDNA methylation classifier demonstrated a training AUC of 1.00, test AUC of 0.93, and tissue AUC of 0.96, showing exceptional accuracy.
Progressive methylation changes correlate with tumor aggressiveness, providing insights into lung cancer progression.

Cite This Study

Zhou et al. (2026) studied this question.

synapsesocial.com/papers/6a2a503380c8f91e7f39cb95 https://doi.org/10.1186/s12967-026-08382-w

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark